Abbott Laboratories’ top executive said that the company is ramping up production of its Covid-19 tests after the convergence of a highly contagious variant with the holiday travel season led to an unprecedented surge in demand.
Chief Executive Officer Robert Ford said that Abbott expects to produce 70 million of its at-home BinaxNOW tests this month, and that “I am working with my team every day to see if we can get us to 100 million.”
Abbott CEO Robert Ford discusses the company’s new bio-wearable devices and efforts to address the surge in demand for at-home Covid-19 tests.
The omicron variant has spread widely, driving daily new case counts to pandemic records. The rapid spread of the new strain has ...